8-K/A: Cardlytics Appoints Amit Gupta as CEO, Details Compensation Package

Cardlytics has appointed Amit Gupta as its new CEO, effective August 16, 2024, and disclosed his compensation package including salary, bonuses, and stock options.

Summary

• Cardlytics announced the resignation of Karim Temsamani as CEO, effective August 16, 2024.
• Amit Gupta, previously COO, has been appointed as the new CEO, also effective August 16, 2024.
• Mr. Gupta's compensation includes an annual base salary of $550,000 and a one-time promotion bonus of $275,000.
• He is eligible for an annual bonus targeted at 100% of his base salary.
• Mr. Gupta will receive 500,000 restricted stock units (RSUs) that vest over 24 months.
• An additional 500,000 RSUs are planned for January 2025, vesting over 18 months.
• The company also plans to grant additional RSUs and/or performance stock units with a value of $5,000,000 by May 31, 2025.
• Mr. Gupta will also join the Board of Directors.
• If Mr. Gupta leaves within 12 months, he must repay the pre-tax value of vested shares.
• Mr. Gupta remains eligible for severance as per his existing agreement.

Sentiment

Score: 7

Explanation: The document reflects a planned leadership transition with a clear compensation package for the new CEO. While there is a change in leadership, the appointment of an internal candidate and the structured compensation plan suggest a stable outlook.

Positives

• The company has quickly filled the CEO position with an internal candidate, ensuring continuity.
• The compensation package for the new CEO is clearly defined, providing transparency.
• The vesting schedule for the RSUs incentivizes long-term commitment from the new CEO.
• The clawback provision on the promotion bonus and vested shares protects the company's interests.

Negatives

• The departure of the previous CEO, Karim Temsamani, may create some uncertainty.
• The company will need to file an additional amendment to disclose the full details of the amended compensatory arrangements with Mr. Gupta.

Risks

• The new CEO's performance will be critical to the company's future success.
• The company faces the risk of Mr. Gupta leaving within 12 months, requiring repayment of vested shares.
• The company needs to ensure the new CEO's compensation package aligns with shareholder interests.

Future Outlook

The company expects to file an amendment to this report with the full details of the amended compensatory arrangements with Mr. Gupta and intends to file the Offer Letter as an exhibit to the Quarterly Report on Form 10-Q for the quarter ending September 30, 2024.

Management Comments

• Karim Temsamani's resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

Industry Context

Executive transitions are common in the tech industry, and this change at Cardlytics reflects a strategic shift in leadership. The appointment of an internal candidate suggests a focus on continuity and leveraging existing expertise.

Comparison to Industry Standards

• The compensation package for the new CEO, including base salary, bonus, and stock options, is generally in line with industry standards for similar roles at comparable technology companies.
• The vesting schedule for the RSUs is a common practice to incentivize long-term performance and retention.
• The clawback provision on the promotion bonus and vested shares is also a standard practice to protect the company's interests.

Management Changes

Stakeholder Impact

• Shareholders will be impacted by the change in leadership and the associated compensation package.
• Employees will be impacted by the change in leadership and the new direction of the company.
• Customers and suppliers may be impacted by any strategic changes implemented by the new CEO.

Next Steps

• The company will file an amendment to this report with the full details of the amended compensatory arrangements with Mr. Gupta.
• The company will file the Offer Letter as an exhibit to the Quarterly Report on Form 10-Q for the quarter ending September 30, 2024.
• The Board or the Compensation Committee will approve the additional RSU grants in January 2025 and by May 31, 2025.

Key Dates

Keywords

CEO, executive compensation, appointment, resignation, restricted stock units, RSUs, bonus, Cardlytics, management change